Amedisys Company Profile (NASDAQ:AMED)

About Amedisys

Amedisys logoAmedisys, Inc. (Amedisys) is a provider of home health and hospice services. The Company offers home health services to the chronic, co-morbid, aging American population. The Company operates through three segments: home health, hospice and personal care. The Company's home health segment delivers a range of services in the homes of individuals recovering from surgery, have a chronic disability or terminal illness or need assistance with completing important personal tasks. The Company's hospice segment provides palliative care and comfort to terminally ill patients and their families. The Company's personal care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 330 Medicare-certified home healthcare centers, over 80 Medicare-certified hospice care centers and approximately nine personal-care care centers in over 30 states within the United States, the District of Columbia and Puerto Rico.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Home Health Care
  • Sub-Industry: Health Care Services
  • Exchange: NASDAQ
  • Symbol: AMED
  • CUSIP: 02343610
Key Metrics:
  • Previous Close: $49.50
  • 50 Day Moving Average: $48.49
  • 200 Day Moving Average: $49.43
  • 52-Week Range: $33,547,000.00 - $31.16
  • Trailing P/E Ratio: 42.62
  • Foreward P/E Ratio: 22.56
  • P/E Growth: 1.11
  • Market Cap: $1.63B
  • Outstanding Shares: 33,547,000
  • Beta: 1.05
Profitability:
  • Net Margins: 2.78%
  • Return on Equity: 12.17%
  • Return on Assets: 7.22%
Debt:
  • Debt-to-Equity Ratio: 0.21%
  • Current Ratio: 0.95%
  • Quick Ratio: 0.95%
Additional Links:
Companies Related to Amedisys:

Analyst Ratings

Consensus Ratings for Amedisys (NASDAQ:AMED) (?)
Ratings Breakdown: 6 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $51.00 (4.68% upside)

Analysts' Ratings History for Amedisys (NASDAQ:AMED)
Show:
DateFirmActionRatingPrice TargetDetails
9/11/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details
9/6/2016Jefferies GroupReiterated RatingBuyView Rating Details
8/3/2016MizuhoDowngradeBuy -> Neutral$57.00 -> $55.00View Rating Details
6/16/2016StephensInitiated CoverageEqual Weight$55.00View Rating Details
5/16/2016Robert W. BairdReiterated RatingHoldView Rating Details
5/6/2016Royal Bank Of CanadaBoost Price TargetSector Perform$41.00 -> $48.00View Rating Details
5/4/2016Oppenheimer Holdings Inc.Reiterated RatingBuy$56.00View Rating Details
1/11/2016Raymond James Financial Inc.UpgradeUnderperform -> Market PerformView Rating Details
11/6/2015Piper Jaffray Cos.Reiterated RatingNeutral$42.00 -> $45.00View Rating Details
6/9/2015Deutsche Bank AGUpgradeHold -> Buy$28.00 -> $41.00View Rating Details
5/27/2015SunTrust Banks Inc.UpgradeNeutral -> Buy$31.00 -> $36.00View Rating Details
10/30/2014Credit Suisse Group AGReiterated RatingUnderperform$17.00 -> $23.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Amedisys (NASDAQ:AMED)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/2/2016Q2$0.42$0.42$353.07 million$360.00 millionViewListenView Earnings Details
5/3/2016Q1$0.33$0.33$337.07 million$348.80 millionViewListenView Earnings Details
3/8/2016Q415$0.35$0.40$338.37 millionViewListenView Earnings Details
11/5/2015Q315$0.34$0.34$312.22 million$326.50 millionViewListenView Earnings Details
7/29/2015Q215$0.33$0.43$307.11 million$314.20 millionViewListenView Earnings Details
4/29/2015Q115$0.20$0.30$300.17 million$301.60 millionViewListenView Earnings Details
3/4/2015Q414$0.27$0.27$301.62 million$300.50 millionViewListenView Earnings Details
10/29/2014Q314$0.15$0.26$299.26 million$300.30 millionViewListenView Earnings Details
7/30/2014Q214$0.04$0.25$298.90 million$305.00 millionViewListenView Earnings Details
5/8/2014Q114$0.56($0.07)$301.89 million$298.74 millionViewListenView Earnings Details
3/12/2014Q413($0.01)($0.05)$295.02 million$303.50 millionViewListenView Earnings Details
11/12/2013Q313$0.13$0.06$314.30 million$301.64 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.10$0.06$328.02 million$313.10 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.18$0.13$361.41 million$339.20 millionViewListenView Earnings Details
3/12/2013Q4 2012$0.22$0.24$373.31 million$632.90 millionViewListenView Earnings Details
11/6/2012Q312$0.27$0.33$379.97 million$375.62 millionViewN/AView Earnings Details
8/7/2012$0.24$0.27ViewN/AView Earnings Details
5/8/2012$0.22$0.22ViewN/AView Earnings Details
2/28/2012$0.29$0.25ViewN/AView Earnings Details
11/1/2011$0.50$0.36ViewN/AView Earnings Details
8/2/2011$0.69$0.75ViewN/AView Earnings Details
4/26/2011$0.66$0.53ViewN/AView Earnings Details
2/22/2011$0.91$0.77ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Amedisys (NASDAQ:AMED)
Current Year EPS Consensus Estimate: $1.69 EPS
Next Year EPS Consensus Estimate: $2.16 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20167$0.32$0.35$0.33
Q2 20165$0.38$0.44$0.42
Q3 20165$0.40$0.46$0.43
Q4 20163$0.51$0.53$0.52
Q1 20172$0.43$0.45$0.44
Q2 20172$0.53$0.55$0.54
Q3 20172$0.56$0.56$0.56
Q4 20172$0.62$0.65$0.64
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Amedisys (NASDAQ:AMED)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Amedisys (NASDAQ:AMED)
Insider Ownership Percentage: 2.80%
Institutional Ownership Percentage: 91.45%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/13/2016Bruce D PerkinsDirectorBuy1,000$50.21$50,210.00View SEC Filing  
5/11/2016Scott G GinnInsiderSell6,000$51.62$309,720.00View SEC Filing  
11/2/2015North Tide Capital, LlcMajor ShareholderSell277,720$39.79$11,050,478.80View SEC Filing  
10/28/2015North Tide Capital, LlcMajor ShareholderSell191,400$39.86$7,629,204.00View SEC Filing  
10/26/2015North Tide Capital, LlcMajor ShareholderSell56,400$39.32$2,217,648.00View SEC Filing  
8/18/2015Donald A WashburnDirectorSell20,000$45.51$910,200.00View SEC Filing  
3/13/2015Jeffrey D JeterInsiderSell11,264$27.02$304,353.28View SEC Filing  
3/13/2015Peter RicchiutiDirectorSell2,003$27.25$54,581.75View SEC Filing  
8/5/2014Jeffrey D JeterInsiderSell2,500$21.80$54,500.00View SEC Filing  
5/8/2014North Tide Capital, Llcmajor shareholderBuy500,000$13.90$6,950,000.00View SEC Filing  
5/1/2014North Tide Capital, Llcmajor shareholderBuy150,000$13.54$2,031,000.00View SEC Filing  
11/21/2013Kkr Asset Management Llcmajor shareholderBuy425,515$14.48$6,161,457.20View SEC Filing  
11/15/2013David BuceyGeneral CounselSell8,290$13.95$115,645.50View SEC Filing  
11/14/2013Kkr Asset Management Llcmajor shareholderBuy946,500$13.89$13,146,885.00View SEC Filing  
10/30/2013Kkr Asset Management LlcMajor ShareholderBuy29,615$15.94$472,063.10View SEC Filing  
10/22/2013Kkr Asset Management LlcMajor ShareholderBuy186,013$17.55$3,264,528.15View SEC Filing  
10/18/2013Kkr Asset Management LlcMajor ShareholderBuy12,652$17.95$227,103.40View SEC Filing  
7/3/2013Linda J HallDirectorSell1,721$10.65$18,328.65View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Amedisys (NASDAQ:AMED)
DateHeadline
stocksdaily.net logoCan Amedisys Inc (NASDAQ:AMED) Meet Analysts EPS Expectation Of $0.45? - Stocks Daily (NASDAQ:AMED)
www.stocksdaily.net - September 25 at 3:15 PM
wsj.com logoAfter the Floods, an Outpouring of Help From the CEO (NASDAQ:AMED)
www.wsj.com - September 21 at 9:34 AM
4-traders.com logoAmedisys : After the Floods, an Outpouring of Help From the CEO -- WSJ (NASDAQ:AMED)
www.4-traders.com - September 21 at 9:34 AM
wsj.com logo[$$] After the Floods, an Outpouring of Help From the CEO (NASDAQ:AMED)
www.wsj.com - September 21 at 9:34 AM
News IconShares Have Ticked Up Over the Last Five Trading Sessions: Amedisys Inc. (NASDAQ:AMED) - Post News (NASDAQ:AMED)
www.kentuckypostnews.com - September 20 at 9:21 AM
realistinvestor.com logoAmedisys Inc (NASDAQ:AMED) Mean Price Target Is $54.714 (NASDAQ:AMED)
www.realistinvestor.com - September 17 at 8:15 AM
News IconAnalyst Projections and Growth Recap for Amedisys Inc. (NASDAQ ... - Post News (NASDAQ:AMED)
www.kentuckypostnews.com - September 16 at 3:27 PM
realistinvestor.com logoAmedisys Inc (NASDAQ:AMED) Mean Price Target Is $54.714 - RealistInvestor.com (NASDAQ:AMED)
www.realistinvestor.com - September 16 at 3:27 PM
4-traders.com logoAmedisys : Welcomes Susan Sender as New Chief Clinical Officer (NASDAQ:AMED)
www.4-traders.com - September 16 at 12:09 PM
wsj.com logoAfter the Floods, an Outpouring of Help From the CEO - Wall Street Journal (NASDAQ:AMED)
www.wsj.com - September 15 at 3:27 PM
realistinvestor.com logoAmedisys Inc (NASDAQ:AMED) Accounts Payable Is $35.07 - RealistInvestor.com (NASDAQ:AMED)
www.realistinvestor.com - September 15 at 3:26 PM
4-traders.com logoAMEDISYS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) (NASDAQ:AMED)
www.4-traders.com - September 15 at 12:22 PM
realistinvestor.com logoAmedisys Inc (NASDAQ:AMED) Accounts Payable Is $35.07 (NASDAQ:AMED)
www.realistinvestor.com - September 15 at 12:22 PM
News IconMovers & Shakers: Amedisys’ New Chief Clinical Officer (NASDAQ:AMED)
homehealthcarenews.com - September 15 at 12:22 PM
News IconMovers & Shakers: Amedisys' New Chief Clinical Officer - Home Health Care News (NASDAQ:AMED)
homehealthcarenews.com - September 14 at 8:43 PM
investornewswire.com logoAmedisys Inc (NASDAQ:AMED) Handed A Rating Of 2.11 - Investor Newswire (NASDAQ:AMED)
www.investornewswire.com - September 14 at 8:43 PM
globenewswire.com logoAmedisys Welcomes Susan Sender as New Chief Clinical Officer ... - GlobeNewswire (press release) (NASDAQ:AMED)
globenewswire.com - September 14 at 3:28 PM
News IconIs it now a right time to buy Amedisys Inc (AMED)? - Simply Wall St (NASDAQ:AMED)
simplywall.st - September 14 at 3:28 PM
biz.yahoo.com logoAMEDISYS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:AMED)
biz.yahoo.com - September 14 at 3:28 PM
publicnow.com logoAmedisys Welcomes Susan Sender as New Chief Clinical Officer (NASDAQ:AMED)
www.publicnow.com - September 14 at 3:28 PM
News IconStock Up Over the Past Five Trading Sessions: Amedisys Inc. (NASDAQ:AMED) - Post News (NASDAQ:AMED)
www.kentuckypostnews.com - September 13 at 3:27 PM
News IconAnalyst Expectations and Growth Review for Amedisys Inc. (NASDAQ:AMED) - Post News (NASDAQ:AMED)
www.kentuckypostnews.com - September 13 at 3:27 PM
News IconAnalysts Place Amedisys Inc (NASDAQ:AMED) Under the Lens of the Microscope - Post News (NASDAQ:AMED)
www.kentuckypostnews.com - September 12 at 8:16 AM
News IconShares Lower Over the Past Quarter: Amedisys Inc. (NASDAQ:AMED) - Post News (NASDAQ:AMED)
www.kentuckypostnews.com - September 11 at 8:13 AM
News IconEditor's Picks: Amedisys CEO on Boosting Star Ratings - Home Health Care News (NASDAQ:AMED)
homehealthcarenews.com - September 10 at 8:12 AM
realistinvestor.com logoA Price Target Of $54.714 Is Set By Research Analysts For Amedisys Inc (NASDAQ:AMED) - RealistInvestor.com (NASDAQ:AMED)
www.realistinvestor.com - September 8 at 3:26 PM
streetinsider.com logoForm 3 AMEDISYS INC For: Aug 29 Filed by: Sender Susan - StreetInsider.com (NASDAQ:AMED)
www.streetinsider.com - September 8 at 11:04 AM
News IconWhat are Research Firms Saying About Amedisys Inc (NASDAQ:AMED)? - Frisco Fastball (NASDAQ:AMED)
friscofastball.com - September 7 at 8:38 PM
News IconAmedisys Inc. (NASDAQ: AMED) Stock Rating Reiterated at Jefferies Group - BNB Daily (blog) (NASDAQ:AMED)
www.baseball-news-blog.com - September 7 at 3:29 PM
globenewswire.com logoAmedisys Closes Professional Profiles Acquisition - GlobeNewswire (press release) (NASDAQ:AMED)
globenewswire.com - September 3 at 3:25 PM
streetinsider.com logoForm 8-K AMEDISYS INC For: Sep 02 - StreetInsider.com (NASDAQ:AMED)
www.streetinsider.com - September 2 at 8:06 AM
publicnow.com logoAmedisys Closes Professional Profiles Acquisition (NASDAQ:AMED)
www.publicnow.com - September 2 at 8:05 AM
News IconShares Slipping Lower Over the Past Month: Amedisys Inc. (NASDAQ:AMED) - Post News (NASDAQ:AMED)
www.kentuckypostnews.com - September 1 at 3:27 PM
globenewswire.com logoUpdate in Lawsuit for Investors in Amedisys Inc (NASDAQ:AMED) shares announced by Shareholders Foundation - GlobeNewswire (press release) (NASDAQ:AMED)
globenewswire.com - August 31 at 8:14 AM
publicnow.com logoAmedisys to Present at Investor Conferences (NASDAQ:AMED)
www.publicnow.com - August 30 at 3:27 PM
finance.yahoo.com logoUpdate in Lawsuit for Investors in Amedisys Inc (NASDAQ:AMED) shares announced by Shareholders Foundation (NASDAQ:AMED)
finance.yahoo.com - August 30 at 11:50 AM
nasdaq.com logoAmedisys Becomes Oversold (AMED) (NASDAQ:AMED)
www.nasdaq.com - August 26 at 3:27 PM
News IconInvestor Lawsuit Against Amedisys Moving Forward (NASDAQ:AMED)
homehealthcarenews.com - August 25 at 8:16 AM
News IconAmedisys in Crisis Management After Louisiana Flooding (NASDAQ:AMED)
homehealthcarenews.com - August 22 at 8:36 PM
News IconEditor’s Picks: Amedisys Founder Identified Among Flood Victims (NASDAQ:AMED)
homehealthcarenews.com - August 19 at 4:04 PM
News IconWall Street Outlook and Growth Projections for Amedisys Inc. (NASDAQ:AMED) - Post News (NASDAQ:AMED)
www.kentuckypostnews.com - August 18 at 3:35 PM
News IconAmedisys founder dies in Louisiana floods (NASDAQ:AMED)
www.hartfordbusiness.com - August 17 at 3:30 PM
News IconAmedisys Founder Identified Among Baton Rouge Flood Victims (NASDAQ:AMED)
homehealthcarenews.com - August 16 at 8:46 PM
tradecalls.org logoShares of Amedisys Inc (AMED) Sees Large Outflow of Money - Trade Calls (NASDAQ:AMED)
www.tradecalls.org - August 10 at 10:17 AM
equities.com logoAmedisys Inc (AMED) is Trading Lower on Unusual Volume for August 08 (NASDAQ:AMED)
www.equities.com - August 9 at 10:05 PM
streetinsider.com logoForm 4 AMEDISYS INC For: Aug 05 Filed by: Carmody Jane (NASDAQ:AMED)
www.streetinsider.com - August 9 at 4:35 PM
streetinsider.com logoForm 4 AMEDISYS INC For: Aug 05 Filed by: Carmody Jane - StreetInsider.com (NASDAQ:AMED)
www.streetinsider.com - August 9 at 12:13 PM
equities.com logoAmedisys Inc (AMED) Drops 5.02% on August 03 - Equities.com (NASDAQ:AMED)
www.equities.com - August 5 at 3:29 PM
capitalcube.com logoETF’s with exposure to Amedisys, Inc. : August 5, 2016 (NASDAQ:AMED)
www.capitalcube.com - August 5 at 3:29 PM
capitalcube.com logoAmedisys, Inc. :AMED-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:AMED)
www.capitalcube.com - August 5 at 11:53 AM

Social

Amedisys (NASDAQ:AMED) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff